These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

457 related articles for article (PubMed ID: 22474480)

  • 1. Incomplete immune recovery in HIV infection: mechanisms, relevance for clinical care, and possible solutions.
    Gaardbo JC; Hartling HJ; Gerstoft J; Nielsen SD
    Clin Dev Immunol; 2012; 2012():670957. PubMed ID: 22474480
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Poor immune reconstitution in HIV-infected patients associates with high percentage of regulatory CD4+ T cells.
    Horta A; Nobrega C; Amorim-Machado P; Coutinho-Teixeira V; Barreira-Silva P; Boavida S; Costa P; Sarmento-Castro R; Castro AG; Correia-Neves M
    PLoS One; 2013; 8(2):e57336. PubMed ID: 23437372
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Suboptimal immune reconstitution in vertically HIV infected children: a view on how HIV replication and timing of HAART initiation can impact on T and B-cell compartment.
    Cotugno N; Douagi I; Rossi P; Palma P
    Clin Dev Immunol; 2012; 2012():805151. PubMed ID: 22550537
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rapid CD4 decline prior to antiretroviral therapy predicts subsequent failure to reconstitute despite HIV viral suppression.
    Darraj M; Shafer LA; Chan S; Kasper K; Keynan Y
    J Infect Public Health; 2018; 11(2):265-269. PubMed ID: 28826735
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thymic function in HIV-infection.
    Kolte L
    Dan Med J; 2013 Apr; 60(4):B4622. PubMed ID: 23651726
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Limited immune restoration after 3 years' suppression of HIV-1 replication in patients with moderately advanced disease.
    Valdez H; Connick E; Smith KY; Lederman MM; Bosch RJ; Kim RS; St Clair M; Kuritzkes DR; Kessler H; Fox L; Blanchard-Vargas M; Landay A;
    AIDS; 2002 Sep; 16(14):1859-66. PubMed ID: 12351945
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunodiscordant responses to HAART--mechanisms and consequences.
    Massanella M; Negredo E; Clotet B; Blanco J
    Expert Rev Clin Immunol; 2013 Nov; 9(11):1135-49. PubMed ID: 24168417
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The predictive role of CD4
    Li CX; Li YY; He LP; Kou J; Bai JS; Liu J; Tian B; Cao LJ; Wang KH; Kuang YQ
    BMC Immunol; 2019 Aug; 20(1):31. PubMed ID: 31455209
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Discordant responses to cART in HIV-1 patients in the era of high potency antiretroviral drugs: clinical evaluation, classification, management prospects.
    Cenderello G; De Maria A
    Expert Rev Anti Infect Ther; 2016; 14(1):29-40. PubMed ID: 26513236
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Altered clonogenic capability and stromal cell function characterize bone marrow of HIV-infected subjects with low CD4+ T cell counts despite viral suppression during HAART.
    Isgrò A; Leti W; De Santis W; Marziali M; Esposito A; Fimiani C; Luzi G; Pinti M; Cossarizza A; Aiuti F; Mezzaroma I
    Clin Infect Dis; 2008 Jun; 46(12):1902-10. PubMed ID: 18462177
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cell-Associated HIV-1 Unspliced-to-Multiply-Spliced RNA Ratio at 12 Weeks of ART Predicts Immune Reconstitution on Therapy.
    Scherpenisse M; Kootstra NA; Bakker M; Berkhout B; Pasternak AO
    mBio; 2021 Mar; 12(2):. PubMed ID: 33688002
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term mortality in HIV patients virally suppressed for more than three years with incomplete CD4 recovery: a cohort study.
    Engsig FN; Gerstoft J; Kronborg G; Larsen CS; Pedersen G; Røge B; Jensen J; Nielsen LN; Obel N
    BMC Infect Dis; 2010 Nov; 10():318. PubMed ID: 21044307
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Responsiveness of T cells to interleukin-7 is associated with higher CD4+ T cell counts in HIV-1-positive individuals with highly active antiretroviral therapy-induced viral load suppression.
    Camargo JF; Kulkarni H; Agan BK; Gaitan AA; Beachy LA; Srinivas S; He W; Anderson S; Marconi VC; Dolan MJ; Ahuja SK
    J Infect Dis; 2009 Jun; 199(12):1872-82. PubMed ID: 19432535
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Incomplete CD4 T cell recovery in HIV-1 infection after 12 months of highly active antiretroviral therapy is associated with ongoing increased CD4 T cell activation and turnover.
    Anthony KB; Yoder C; Metcalf JA; DerSimonian R; Orenstein JM; Stevens RA; Falloon J; Polis MA; Lane HC; Sereti I
    J Acquir Immune Defic Syndr; 2003 Jun; 33(2):125-33. PubMed ID: 12794543
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulatory T Cell Counts and Development of Malignancy in Patients with HIV Infection.
    Politou M; Boti S; Androutsakos T; Kontos A; Pouliakis A; Kapsimali V; Panayiotakopoulos G; Kordossis T; Karakitsos P; Sipsas NV
    Curr HIV Res; 2020; 18(3):201-209. PubMed ID: 32234003
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sub-optimal CD4 recovery on long-term suppressive highly active antiretroviral therapy is associated with favourable outcome.
    Onen NF; Overton ET; Presti R; Blair C; Powderly WG; Mondy K
    HIV Med; 2009 Aug; 10(7):439-46. PubMed ID: 19459993
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Failure to reconstitute CD4+ T-cells despite suppression of HIV replication under HAART.
    Aiuti F; Mezzaroma I
    AIDS Rev; 2006; 8(2):88-97. PubMed ID: 16848276
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activated dendritic cells and monocytes in HIV immunological nonresponders: HIV-induced interferon-inducible protein-10 correlates with low future CD4+ recovery.
    Stiksrud B; Aass HCD; Lorvik KB; Ueland T; Trøseid M; Dyrhol-Riise AM
    AIDS; 2019 Jun; 33(7):1117-1129. PubMed ID: 30789356
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The decrease of regulatory T cells correlates with excessive activation and apoptosis of CD8+ T cells in HIV-1-infected typical progressors, but not in long-term non-progressors.
    Jiao Y; Fu J; Xing S; Fu B; Zhang Z; Shi M; Wang X; Zhang J; Jin L; Kang F; Wu H; Wang FS
    Immunology; 2009 Sep; 128(1 Suppl):e366-75. PubMed ID: 19016904
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunological recovery, failure and factors associated with CD-4 T-cells progression over time, among adolescents and adults living with HIV on Antiretroviral Therapy in Northern Ethiopia: A retrospective cross sectional study.
    Desta AA; Wubayehu Woldearegay T; Berhe AA; Futwi N; Gebremedhn Gebru G; Godefay H
    PLoS One; 2019; 14(12):e0226293. PubMed ID: 31830095
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.